In triple-negative breast cancer [65], the EGFR-MAPK signaling pathway regulates the expression of the low-density lipoprotein receptor (LDLR), which acts as a key molecule in mediating the uptake of cholesterol. The gene discussed is LDLR; the disease is triple-negative breast carcinoma.